This prospective randomized study evaluated the effects of ketamine with remifentanil to improve the quality of anaesthesia and postoperative recovery, following brief procedures, in 60 paediatric patients undergoing middle-ear ventilation tube insertion (MEVTI). Patients were randomly assigned to either ketamine 2 mg/kg intravenous [i.v.] bolus plus normal saline by i.v. infusion (K group, n = 30) or ketamine 2 mg/kg i.v. bolus, plus remifentanil 0.15 µg/kg per min i.v. infusion (KR group, n = 30). Parameters that were assessed included intraoperative patient movement, surgeon satisfaction, anaesthesia time, total ketamine dose, postoperative recovery time, agitation and side-effects.
Introduction
Middle-ear ventilation tube insertion (MEVTI) is one of the most common outpatient surgical procedures undertaken in children. MEVTI can be performed under face-mask inhalational anaesthesia with sevoflurane 1 or under intravenous (i.v.) anaesthesia. 2 Because MEVTI frequently accompanies upper respiratory tract infection, inhalational anaesthesia increases the risk of laryngospasm; 3 in addition, sevoflurane evokes a high incidence of emergence delirium. 4 Thus, we prefer to use i.v. anaesthesia for MEVTI.
Ketamine induces a trance-like cataleptic state of 'sensory isolation' characterized by Ketamine with remifentanil for brief procedures in children potent analgesia, sedation and amnesia, while maintaining cardiovascular stability and preserving spontaneous respiration and protective airway reflexes. 5 -8 Thus, ketamine is used in the emergency department 3, 9 and for the sedation of uncooperative paediatric patients during brief painful or emotionally disturbing procedures in outpatient settings. 2 The minimum dose of ketamine at which the dissociative state is induced in children is 1.5 mg/kg i.v.; common loading doses of ketamine are 1.5 -2.0 mg/kg. 7, 10 Once the dissociative threshold is reached, administration of additional ketamine does not enhance or deepen sedation. 7, 11 Thus, it is generally recommended not to exceed a ketamine dose of 2 mg/kg. 12 In clinical use, however, repeated incremental doses of ketamine of 0.5 -1.0 mg/kg may be administered because the loading dose is often not enough to provide adequate anaesthesia. 7, 10 Ketamine administration in children has several side-effects including a prolonged recovery period, emergence delirium, dizziness, nausea, vomiting and increased secretion. 13 Thus, it is preferable to add other sedatives or analgesics as adjuvants to ketamine, to reduce these sideeffects and improve the quality of procedural sedation and analgesia. 13 -15 Remifentanil is an ultra-short-acting opioid, without an active metabolite, that provides effective sedation, rapid onset, rapid recovery, easy titration, reduced nausea and vomiting, and decreased postoperative delirium. 16 Thus, remifentanil can be administered as an adjuvant to ketamine, for brief procedures. Reports in the literature about the combined administration of ketamine and remifentanil are, however, rare. 17 The present prospective, randomized study assessed the effect of ketamine with remifentanil for improving the quality of anaesthesia and recovery in paediatric patients undergoing MEVTI.
Patients and methods

STUDY POPULATION
Consecutive children who were scheduled to undergo bilateral MEVTI in the Department of Otolaryngology, Saint Vincent Hospital, The Catholic University of Korea, Gyeonggido, Republic of Korea, between August 2010 and March 2011, were enrolled in the study. Patients aged 2 -10 years, with an American Society of Anesthesiologists physical classification status I or II were included. Patients with psychiatric problems, history of seizure, increased intraocular pressure or fever were excluded from the study.
This prospective randomized study was approved by the Institutional Review Board of Saint Vincent Hospital, The Catholic University of Korea. Written informed consent was obtained from the parents of all children included in the study.
ANAESTHETIC PROCEDURES
Topical skin anaesthesia for venous cannulation was provided with EMLA ® cream (AstraZeneca, Södertälje, Sweden), which was applied 60 min before the operation under an occlusive dressing. Premedication was not given. Using a sealedenvelope method, patients were randomly divided into two groups: the ketamine group (K group) and the ketamine with remifentanil group (KR group).
Patients arrived into the operating room with a parent present. Oxygen saturation (SpO 2 ) via pulse oximetry, heart rate (HR) and electrocardiogram were monitored. The KR group received ketamine 2 mg/kg i.v. bolus plus remifentanil 0.15 µg/kg per min via i.v. infusion. The K group received ketamine 2 mg/kg i.v. bolus plus normal Ketamine with remifentanil for brief procedures in children saline i.v. infusion of equivalent volume to that of remifentanil. All patients also received glycopyrrolate 0.05 -0.07 mg i.v. bolus. After the patient's responses were reduced, the operation was started. If the patient moved or moaned, an additional dosage of ketamine 0.5 mg/kg, i.v. bolus, was administered.
STUDY ASSESSMENTS
Patient movement, surgeon satisfaction, anaesthesia time, total dose of ketamine administered, HR, incidence of a reduction of SpO 2 to < 90% and other complications (such as laryngospasm) were recorded during the operation. Patient movement was scored as follows: 0, no movement; 1, upper and/or lower extremity movement; 2, trunk movement; 3, head movement. Surgeon satisfaction was rated as follows: good, comfortable to perform the procedure; borderline, somewhat difficult to perform the procedure because of patient movement; bad, very difficult to perform the procedure because of vigorous patient movement. Anaesthesia time was defined as the time from the start of ketamine administration to the end of surgery.
After patients arrived at the recovery room, a nurse (who was blinded to the patient groups) evaluated their recovery. The time to when the patient could open their eyes and the time to when the Aldrete recovery score 18 rose to ≥ 9 were measured. Side-effects such as dizziness, nausea, vomiting and postoperative agitation were also recorded. Postoperative agitation was scored as follows: 19 1, calm; 2, agitated, but consolable; 3, severely agitated and inconsolable. A score of 3 was regarded as clinically important emergence agitation.
STATISTICAL ANALYSES
Based on the reported incidence of side-effects with ketamine, 3 with a power of 80% and an α-error of 0.05, it was calculated that 30 patients were required in each group to detect a 30% decrease in the incidence of side-effects by the addition of remifentanil.
Statistical analyses were carried out using the SPSS ® statistical software, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Parametric variables are expressed as mean ± SD. An unpaired t-test was used to evaluate the statistical differences between the two groups with respect to age, sex, weight, height, anaesthesia time, total ketamine dose, HR and recovery time. Intraoperative patient movement, surgeon satisfaction and side-effects were analysed using the Fisher's exact test. A value of P < 0.05 was considered statistically significant.
Results
Sixty consecutive children undergoing MEVTI were randomly assigned into the two study groups: the K group (n = 30) and the KR group (n = 30). There were no statistically significant differences between the two groups with regard to patient demographics (Table 1) .
Intraoperative characteristics are shown in Table 2 . Patient movement scores were significantly lower in the KR group than in the K group (P < 0.01), and surgeon satisfaction was significantly higher in the KR group than in the K group (P < 0.02). Significantly lower total doses of ketamine were used for maintenance in the KR group than the K group (P < 0.01). The reduction of SpO 2 to < 90% and other adverse events did not occur in either group.
Postoperative recovery characteristics are shown in Table 3 . The mean time to opening their eyes and to reach Aldrete recovery scores of ≥ 9 were significantly reduced in children in the KR group compared with the K group (P < 0.01 for both comparisons). The Ketamine with remifentanil for brief procedures in children incidence of side-effects was also significantly lower in the KR group compared with the K group (P < 0.05).
Discussion
The present study demonstrated that, in paediatric patients undergoing MEVTI, the combined administration of ketamine with remifentanil for anaesthesia was superior to ketamine alone.
The dissociative agent ketamine has, for nearly two decades, been the single most 20 Owens et al. 21 used i.v. ketamine for painful procedures in paediatric patients with burns, and developed a training programme with a strict sedation protocol, to enable professionals who were not anaesthesiologists to use ketamine safely and effectively during bedside procedures in these children.
Although ketamine does not exhibit any dose-related adverse events within the range of clinically administered doses when using the standard administration technique, 7, 8, 20, 22 its administration may create some problems. Thus, many studies investigating alternatives or combined administration regimens for brief procedures have been performed. For example, the concomitant use of ketamine and a benzodiazepine to mitigate emergence agitation is commonly advocated. 3, 7 Other reserach has shown, however, that the addition of a benzodiazepine does not reduce emergence agitation; 23 in addition, significant hypoxia has been reported with this strategy, 24 together with a delay in recovery time of approximately 30% compared with ketamine use alone. 9 Furthermore, prophylactic anticholinergics and prophylactic benzodiazepines are no longer recommended for children. 3, 25 Remifentanil gives an option for providing an intense opioid effect without compromising recovery after short operations. 26 Procedural sedation and analgesia with remifentanil usually have the risk of desaturation or hypoxaemia. Ketamine also has a mild respiratory depressive effect; 27 this effect is also associated with remifentanil use. 28 Malherbe et al. 29 described the successful use of propofol and remifentanil for airway endoscopy in children; and Litman 30 reported effective analgesia using a combination of remifentanil and midazolam in 20 children undergoing painful procedures. The risk of significant respiratory depression was acknowledged in these two studies. 29, 30 The present study did not demonstrate any decrease in oxygen saturation caused by respiratory depression. Thus, the use of 
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ketamine was probably helpful for respiratory maintenance. Ansermino et al. 28 reported that the maximum dose of remifentanil tolerated by children breathing spontaneously under anaesthesia varies widely (0.05 -0.3 µg/kg per min). A remifentanil dose of 0.05 µg/kg per min allows spontaneous respiration in > 90% of children. 28 A remifentanil infusion rate of 0.15 µg/kg per min, i.v., was chosen in the present study because it was being used as an adjuvant to ketamine.
Ketamine may cause random head or extremity movement, unrelated to noxious stimuli. 31 Although the severity of this effect may not been enough to interfere with the performed procedure, for procedures that require motionless sedation, such as computed tomography or magnetic resonance imaging, ketamine is less effective than other agents such as propofol. 31 The KR group in the present study showed significantly reduced rates of intraoperative movement compared with the K group. This might be related to the use of a smaller dose of ketamine in the KR versus the K group (see Table 2 ), and the infusion of a small dose of remifentanil. 32 Ketamine also has some psychomimetic effects. Although the incidence of clinically important agitation reactions varies widely (5 -15%), 33 it was reported to be 1.4% in a large meta-analysis involving paediatric patients. 22 Important (i.e. severe) emergence agitation was also rare in the present study, only occurring in one patient (3.3%) in each group. Pain and discomfort in preverbal and preschool-aged children may, however, be indistinguishable from behaviour associated with delirium on emergence from anaesthesia, 4 and might have led to the underreporting of psychomimetic side-effects in the present study. Also, in the present study, 43.3% of patients (n = 13) receiving ketamine alone had agitation scores of 2, compared with 10.0% of patients (n = 3) receiving ketamine and remifentanil. This may be explained by the fact that remifentanil decreases postoperative delirium. 16 Dizziness after ketamine use is common as a result of transient diplopia. 3 In contrast, patients who received ketamine with remifentanil in the present study showed reduced rates of dizziness, probably because of the use of remifentanil and smaller doses of ketamine. These patients also demonstrated reduced rates of nausea and vomiting, and quicker time to recovery.
There were some limitations to the present study. First, the sedation regimens used might only be suitable for brief procedures and may not be adequate for longer procedures. Secondly, side-effects were only evaluated in the operating and recovery rooms.
In conclusion, the combined administration of ketamine 2 mg/kg i.v. bolus and remifentanil (0.15 µg/kg per min i.v. infusion) for children undergoing MEVTI reduced patient movement scores and increased surgeon satisfaction scores. In addition, this combination of ketamine with remifentanil reduced the recovery time and the incidence of side-effects in the operating and recovery rooms. Thus, remifentanil may be used in children as a good adjuvant to ketamine for brief painful procedures that require sedation and deep analgesia.
